- Home
- CASI vs SPPL Comparison
CASI vs SPPL Comparison
Compare CASI & SPPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CASI | SPPL |
|---|---|---|
| Founded | 1991 | 2016 |
| Country | China | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.7M | 17.4M |
| IPO Year | 1996 | 2023 |
Fundamental Metrics
Financial Performance| Metric | CASI | SPPL |
|---|---|---|
| Price | $0.82 | $2.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 26.1K | 4.0K |
| Earning Date | 03-30-2026 | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $26,846,000.00 | $4,591,508.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 21.72 | ★ 24.27 |
| 52 Week Low | $0.74 | $2.18 |
| 52 Week High | $3.09 | $7.00 |
Technical Indicators
Market Signals| Indicator | CASI | SPPL |
|---|---|---|
| Relative Strength Index (RSI) | 38.96 | 34.59 |
| Support Level | $0.74 | $2.97 |
| Resistance Level | $0.97 | $3.25 |
| Average True Range (ATR) | 0.09 | 0.27 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 19.74 | 34.95 |
Price Performance
Historical ComparisonAbout CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
About SPPL SIMPPLE LTD.
Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions, and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software. The majority of its revenue is generated from the Robots segment.